E2 ModerateModerate confidencePEM unclearCase-ControlPeer-reviewedMachine draft
Higher heart rate and reduced heart rate variability persist during sleep in chronic fatigue syndrome: a population-based study.
Boneva, Roumiana S, Decker, Michael J, Maloney, Elizabeth M et al. · Autonomic neuroscience : basic & clinical · 2007 · DOI
Quick Summary
This study found that people with ME/CFS have a faster heart rate and less heart rate variability (natural changes in heartbeat speed) during sleep compared to healthy people. These differences suggest that the nervous system in ME/CFS patients stays more activated even during sleep, which may be related to chemical imbalances in the body.
Why It Matters
This study provides objective physiological evidence that ANS dysfunction in ME/CFS persists during sleep, not just during wakefulness, supporting the hypothesis that abnormal autonomic regulation is a core feature of the disease. Understanding these sleep-specific changes may lead to targeted interventions and validates the autonomic dysfunction pathway as a potential therapeutic target.
Observed Findings
- CFS patients had significantly higher mean heart rate during sleep (71.4 bpm) compared to controls (64.8 bpm), with shorter mean RR intervals (840.4 ms vs 925.4 ms).
- CFS patients showed reduced low-frequency, very-low-frequency, and total power HRV parameters compared to controls.
- CFS patients had significantly lower plasma aldosterone levels and a tendency toward higher plasma norepinephrine levels.
- Heart rate correlated moderately with fatigue and vitality scores (r=0.46 and r=-0.49, respectively).
- Even among subjects with similar physical activity limitations, CFS patients retained higher sleep heart rate than matched controls (71.8 vs 64.9 bpm).
Inferred Conclusions
- Increased heart rate and reduced HRV during sleep in CFS suggest persistent sympathetic nervous system predominance during sleep.
- Neuroendocrine alterations (higher norepinephrine, lower aldosterone) accompany the autonomic dysfunction in CFS.
- Reduced physical activity contributes to but does not fully explain ANS abnormalities in CFS.
Remaining Questions
- What are the underlying mechanisms driving sympathetic predominance and neuroendocrine alterations in CFS?
- Do these ANS abnormalities improve with treatment, or are they stable biomarkers of disease?
What This Study Does Not Prove
This study does not establish causation—it shows correlation between HRV/HR patterns and ME/CFS but does not prove whether autonomic dysfunction causes CFS symptoms or results from them. The study also does not explain the underlying mechanism of sympathetic predominance or identify whether these ANS changes are reversible with treatment.
Tags
Symptom:Unrefreshing SleepFatigue
Biomarker:Blood Biomarker
Method Flag:PEM Not DefinedSmall Sample
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →